Company News /
by Katrina Bullock -
4 months ago
18 Jun 2020 - Digital health company, ResApp Health (ASX:RAP) has signed a memorandum of understanding with global health product manufacturer, RB.
Market Reports /
by Rachael Jones -
5 months ago
06 May 2020 - The ASX failed to rise into positive territory today closing 0.4% lower. Nearmap (ASX:NEA) shares are on the rise as are Appen (ASX:APX). Shares in National Storage R…
Company News /
by Rachael Jones -
5 months ago
06 May 2020 - Digital health company ResApp Health (ASX:RAP) has received a set of final design files, reports and supporting documents for the handheld and wearable devices under …
Company News /
by Katrina Bullock -
11 months ago
15 Nov 2019 - Digital health company ResApp Health (ASX:RAP) has penned an agreement which grants Sanofi an exclusive license to use the outcomes generated under the Startup Creasp…
Company News /
by Katrina Bullock -
A year ago
04 Oct 2019 - Digital health company, ResApp Health (ASX:RAP) has been selected to join the Startup Creasphere Digital Health Program in Munich.
Market Reports /
by Rachael Jones -
A year ago
02 Oct 2019 - The ASX opened lower following soft leads from Wall Street and is now tracking 1.3% lower at noon. The markets dropped on poor manufacturing results from the US and w…
Market Reports /
by Katrina Bullock -
A year ago
30 Sep 2019 - It’s been a bearish afternoon on the Australian share market. The S&P/ASX 200 index closed 0.4% lower. UBS has downgraded Alumina (ASX:AWC) from a neutral to a sell, …
Company News /
by Anna Napoli -
A year ago
30 Sep 2019 - ResApp (ASX:RAP) has flagged top-line results from its prospective, blinded at-home obstructive sleep apnoea study.
Company News /
by Rachael Jones -
A year ago
26 Sep 2019 - ResApp Health (ASX:RAP) has received CE Mark approval for ResAppDx-EU version 2, the latest version of the world’s first smartphone-based diagnostic test for respirat…
Market Reports /
by Jessica Amir -
A year ago
02 Jul 2019 - Australian share market falls after RBA cut rates as expected to 1%, but the ASX200 claws back into positive territory, rising for the 2nd session. Financials lost ov…
Company News /
by Rachael Jones -
A year ago
29 May 2019 - Digital health company ResApp Health (ASX:RAP) has engaged a UK-based medical device consultant to develop customised hardware and wearable devices capable of running…
Market Reports /
by Rachael Jones -
A year ago
23 Apr 2019 - It has been a positive day of trade for the ASX. After opening in the black the local bourse managed to maintain momentum to gain 1%. Appen (ASX:APX) share price surg…
Company News /
by Rachael Jones -
A year ago
23 Apr 2019 - Digital health smartphone company for respiratory disease, ResApp Health (ASX:RAP) has announced positive top-line results from its Australian Breathe Easy adult clin…
Company Presentations /
by -
A year ago
13 Dec 2018 - ResApp Health Limited (ASX:RAP) Managing Director and CEO Tony Keating provides an update on trial results, regulatory approval for the company's respiratory diagnosi…
Interviews /
by Anna Napoli -
A year ago
13 Dec 2018 - ResApp Health Limited (ASX:RAP) Managing Director and CEO Tony Keating provides an update on trial results, regulatory approval for the company's respiratory diagnosi…
Company News /
by Anna Napoli -
2 years ago
19 Sep 2018 - ResApp (ASX:RAP) has today announced its received firm commitments from institutional and sophisticated investors to raise $7.5 million.
Market Reports /
by Rachael Jones -
2 years ago
06 Jun 2018 - Australian shares opened stronger but struggled to hold gains. We saw a dip prior to the release of the latest GDP figures which were above expectation and the market…
Market Reports /
by Jessica Ellerm -
2 years ago
08 Jan 2018 - Momentum continues on Monday: Aus shares 0.22% higher at noon. ResApp Health Limited (ASX:RAP) announces it has enrolled the first patient in its SMARTCOUGH-C-2 study…
Company Presentations /
by -
3 years ago
18 Sep 2017 - ResApp Health (ASX:RAP) Executive Director Brian Leedman talks about its world's first digital diagnostic smartphone cough app trial results, time frame for FDA appro…
Interviews /
by Jessica Amir -
3 years ago
18 Sep 2017 - ResApp Health (ASX:RAP) Executive Director Brian Leedman talks about the company's trial results from its paediatric and adult programs, time frame for FDA approval a…
Market Reports /
by Carolyn Herbert -
3 years ago
09 Aug 2017 - Back in the black: Aus shares 0.42% higher at noon. ResApp Health (ASX:RAP) shares have been sold off following the company’s latest update on its SMARTCOUGH- C Stud…
Market Reports /
by Carolyn Herbert -
3 years ago
02 Aug 2017 - Negative territory: Aus shares close 0.49% lower. ResApp Health Limited (ASX:RAP) has been placed into voluntary suspension, pending the release of an announcement r…
Market Reports /
by Carolyn Herbert -
3 years ago
31 July 2017 - Sluggish start: Aus shares 0.32% higher at noon. IMF Bentham Limited (ASX:IMF) has announced that it will fund on a conditional basis claims of certain current and …
Company News /
by Carolyn Herbert -
3 years ago
22 Jun 2017 - ResApp Health Limited (ASX:RAP) says it has delivered excellent results in its Australian pediatric SmartCough C study.
Market Reports /
by Carolyn Herbert -
3 years ago
19 June 2017 - In the black: Aus shares 0.52% higher at noon. Pilbara Minerals Limited (ASX:PLS) has announced it has successfully raised $80 million in a heavily oversubscribed p…
